You are here: Industry Insights > COVID-19

News List

New Data From Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 -15 AmericanPharmaceuticalReview
November 23, 2021
Pfizer Inc. and BioNTech SE announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15 years of age.
FDA gives expanded EUA for Pfizer-BioNTech Covid-19 vaccine booster dose Pharmaceutical-Business-Review
November 23, 2021
The expanded EUA allows the administration of booster dose to individuals of 18 years of age and older who have received primary dosages.
Pfizer and BioNTech receive expanded U.S. FDA emergency use suthorization of COVID-19 vaccine booster to include individuals 18 and older WorldPharmaNews
November 23, 2021
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine...
FDA grants expanded EUA to Pfizer-BioNTech’s Covid-19 booster shot Pharmaceutical-Technology
November 23, 2021
The US Food and Drug Administration (FDA) has granted expanded emergency use authorization (EUA) for the booster shot of Pfizer-BioNTech’s Covid-19 vaccine for use in people aged 18 years and above.
EMA CHMP issues advice on usage of Merck-Ridgeback’s Covid-19 medicine Pharmaceutical-Technology
November 23, 2021
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued advice on the usage of Merck Sharp & Dohme and Ridgeback Biotherapeutics’ Lagevrio (molnupiravir/ MK 4482) to treat Covid-19.
Pfizer Says Its COVID Vaccine Provides Full Protection to Adolescents Drugs
November 23, 2021
Pfizer Inc. said Monday that its coronavirus vaccine provides long-term protection in youth ages 12-15, according to data from a company clinical trial that included more than 2,200 participants.
Risk for Stillbirth Elevated for Deliveries With COVID-19 Drugs
November 23, 2021
The risk for stillbirth is elevated in deliveries with versus without COVID-19, according to research published in the Nov. 19 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
iSpecimen Selected by U.S. Government and Private Researchers to Supply Critical Human Biospecimens for Advanced Phase of COVID-19 Research prnewswire
November 23, 2021
iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it has been contracted to support new advanced research...
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time prnasia
November 22, 2021
At 3 a.m. on November 19, the first batch of more than 4 million doses of adenovirus vector COVID-19 vaccines produced by Shenzhen Kangtai Biological Products Co., Ltd. will depart from...
SyneuRx Announces Oral COVID-19 Twindemic Antiviral Drug Candidate Pentarlandir Has Entered Final Portion of FDA Phase II Testing prnasia
November 22, 2021
SyneuRx™ International, (Taipei Exchange, ticker ID TT6575, www.syneurx.com), a pioneering developer of novel CNS (Central Nervous System) and anti-viral pharmaceuticals, today announced that...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page